Proposed revision to NSF/ANSI 455-4 – Good Manufacturing Practices for Over-the-Counter Drugs (455-4i34r1) The proposed revision will update the business continuity plan requirement by adding Section 4.5.57.
06915: Approval of 455-4i34r1 - Section 4.5.57
Document (Archive)
2021-04-01
BLANK Comment Template.docx
Document
2021-03-04
gmp2020-12 455-4i34 with edits from 11-19-20 meeting.pdf
gmp2020-12 455-4i34.pdf
About UsParticipateTerms of UsePrivacy Policy